Quick and Simple Evaluation of Sudomotor Function for Screening of Diabetic Neuropathy
Table 3
Association between ESC measurements in feet and clinical, biochemical and conventional neuropathic characteristics in type 2 diabetic patients.
ESC > 60 (μS)
ESC 40 ≥ & ≤ 60 (μS)
ESC < 40 (μS)
value
()
()
()
Gender
M (74), F (56)
M (38), F (29)
M (37), F (31)
Age (yr)
51.0 (11.5)
53.0 (11.5)
57.0 (10.5)
<0.001
Duration of DM (yr)
6.0 (10.0)
8.0 (10.0)
12.5 (10.5)
<0.001
BMI (kg/m2)
25.9 (5.1)
26.7 (5.2)
26.3 (5.3)
0.88
Waist-hip ratio
0.95 (0.09)
0.96 (0.11)
0.96 (0.11)
0.43
Hemoglobin (gm%)
12.5 (2.3)
12.5 (1.9)
12.1 (2.3)
<0.01
Random glucose (mg%)
169.0 (89.7)
171.0 (99.5)
159.0 (106.7)
0.76
HbA1c (%)
8.0 (2.0)
8.3 (2.6)
8.6 (2.7)
<0.01
Uric acid (mg%)
4.6 (1.7)
4.6 (1.6)
4.5 (1.5)
0.42
Creatinine (mg%)
0.7 (0.3)
0.7 (0.2)
0.8 (0.3)
0.47
eGFR (mL/min/1.73 m2)
111.0 (34.9)
110.0 (38.3)
97.2 (32.0)
0.10
MNSI B score [n (%)]
59 (45%)
38 (56%)
47 (69%)
<0.01
VPT (Volts)
11.5 (7.0)
13.0 (6.5)
15.0 (12.2)
<0.001
Patients with all Ewing tests performed ()
87
52
32
≥2 Abnormal Ewing test [n (%)]
9 (10%)
4 (8%)
10 (31%)
0.01
Values are median (IQR) or N (%). For continuous variables values are calculated using simple linear regression analysis, and for categorical variables using chi square proportion trend test in three ESC categories.
